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ABSTRACT To compare the process of protein folding in
the cell with refolding following denaturation in vitro, we have
investigated and compared the kinetics of renaturation of a
full-length protein upon dilution from concentrated urea with
the rate of folding in the course of biosynthesis. Formation of
enzymatically active bacterial luciferase, an i48 heterodimer,
occurred 2 min after completion of (8-subunit synthesis in an
Escherichia coli cell-free system. Renaturation of urea-
denatured 13 subunit, either in the presence of the cell-free
protein synthesis system or in buffer solutions, proceeded
more slowly. Cellular components present in the cell-free
protein synthesis system slightly accelerated the rate of re-
folding of urea-unfolded ,3 subunit. The results indicate that
the luciferase j3 subunit begins the folding process cotrans-
lationally and that cotranslational folding contributes to the
rapid formation of the native structure in the cell.
The classical approach to the study of protein folding has been
to investigate refolding after transfer from conditions under
which the protein exists primarily as the unfolded molecule to
conditions under which the native structure predominates (1,
2). One of the central questions is how the patterns observed
for refolding in vitro relate to protein folding within the living
cell. There are two main differences between these processes.
First, the nascent polypeptide may start to fold during biosyn-
thesis on the ribosome (3-6). This process could lead to
different intrapeptide contacts during folding from those that
occur during refolding of the covalently intact but unfolded
polypeptide. Second, there are multiple cellular components
that are able to catalyze or assist the folding of newly synthe-
sized polypeptides, such as peptidylprolyl isomerases, protein
disulfide isomerase, and heat shock proteins (7, 8). Moreover,
physicochemical conditions employed for protein renaturation
in vitro often are very different from conditions in vivo.
Protein folding in the cell appears to be significantly faster
than refolding of the denatured protein in vitro, especially for
large oligomeric proteins. However, there are no examples for
which the rate of biosynthetic folding has been determined for
comparison with the refolding of the denatured polypeptide.
The experiments reported here were designed to compare
directly protein refolding with the process of protein folding
during synthesis in a cell-free system in order to determine
whether the protein synthesis mechanism and/or cellular
components present in the cell-free system might contribute to
the overall kinetics of native structure formation in the cell.
Bacterial luciferase, an a/3 heterodimer, was chosen for this
study because of the extremely sensitive enzymatic assay,
which permits monitoring the appearance of the native
polypeptide synthesized in a cell-free expression system.
Knowledge of kinetic (9, 10) and thermodynamic (11, 12)
parameters for the refolding reaction has allowed us to estab-
lish experimental conditions with which to compare the re-
folding reaction with folding during biosynthesis.
MATERIALS AND METHODS
Plasmid Construction. Plasmid pTZ313 was constructed by
ligation of a ca. 1200-base-pairAse I-Pvu II fragment carrying
the luxB gene from pTB7 (13) into the Sma I and Pvu II sites
of the plasmid vector pTZ18R (Pharmacia). The resulting
plasmid, which contained the luxB gene behind the phage T7
promoter, was linearized by NgoMI and used for the produc-
tion of mRNA. A variant of this plasmid with a luxB gene
devoid of the TAA translation stop codon was constructed by
site-directed mutagenesis (14). The stop codon was changed to
TAT, encoding tyrosine, and a Dra I restriction site was
introduced several bases downstream. The plasmid was lin-
earized by Dra I for production of mRNA.
Transcription and Translation. The resultant linearized
plasmids were used for the production of mRNAs with T7
polymerase (Promega) as described (15). The Escherichia coli
cell-free expression system was prepared as described (16).
L-[35S]Methionine (1140 Ci/mmol; 1 Ci = 37 GBq; New
England Nuclear) was used as a radiolabeled marker. Trans-
lation was carried out at 29°C with 70 ,ug of the luciferase
(3-subunit mRNA per ml. The translation mixture was supple-
mented with native luciferase a subunit at a final concentra-
tion of 10 ,ug/ml. To monitor products of synthesis, 5-,ul
aliquots of the translation mixture were added to the sample
buffer for SDS gel electrophoresis and subjected to electro-
phoretic analysis (17); the [35S]methionine-labeled polypep-
tides were visualized by autoradiography. Incorporation of
radioactivity into the full-length ,B subunit was quantitated as
described below.
Separation of the ribosome-bound luciferase 13-subunit nas-
cent chains was achieved by size-exclusion chromatography.
Translation was carried out in a cell-free system (140 ,ul)
supplemented with mRNA for 1 subunit without a stop codon
in the presence of 10 ,ug of a subunit. The translation mixture
was applied to an Ultrogel AcA34 (LKB) column (1 cm x 10
cm) equilibrated with buffer A (20 mM Hepes, pH 7.6/100
mM potassium acetate/10 mM magnesium acetate/i mM
dithiothreitol) and eluted with the same buffer. Fractions of
0.5 ml were collected. The column was calibrated with blue
dextran (2000 kDa) and cytochrome c (12 kDa).
The proportion of the luciferase ,3 subunit in the translation
system supplemented with the mRNA lacking a stop codon
that was ribosome-bound was determined by reaction with
puromycin. Translation in 100 plA was carried out as above; the
mixture was applied onto 0.5 ml of 10% sucrose prepared with
buffer A. Centrifugation in a Beckman TLA 100.2 rotor was
done at 90,000 rpm for 1 hr at 4°C. The pellet was dissolved in
100 plA of 20 mM Hepes buffer, pH 8.0/100 mM potassium
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acetate/10 mM magnesium acetate/i mM dithiothreitol. Two
10-,ul portions were taken, their volumes were adjusted to 50
,ul with the same buffer, and 0.5 ,g of a subunit was added. In
one of them puromycin was added to 1 mM final concentra-
tion. Both samples were incubated 40 min at 29°C and then
recentrifuged as discussed above. Pellets were dissolved in 50
,ul of sample buffer for SDS gel electrophoresis. Aliquots from
the translation mixture and subsequent fractions were sub-
jected to electrophoretic analysis. Incorporation of radioac-
tivity into the full-length 3 subunit was quantitated, and total
incorporation in the corresponding fractions was calculated.
For quantitation of radioactivity incorporated into full-
length 3 subunit, the gels with samples after electrophoretic
separation were exposed in a p-particle imager, ,B-imager 1000
(BioSpace Instruments, Paris) or Betascope 603 (Betagen,
Waltham, MA).
Luciferase 18-Subunit Renaturation. Individual luciferase
subunits were purified from the luciferase heterodimer as
described (10). Renaturation was carried out either in the
translation mixture without added mRNA or in the buffer 20
mM Hepes, pH 7.6/100 mM potassium acetate/i mM mag-
nesium acetate/1 mM dithiothreitol. Native a subunit (11) was
added to a final concentration of 10 ,ug/ml. Renaturation was
initiated by addition of denatured 3 subunit at a final con-
centration of 150 ng/ml.
Measurement of Bioluminescent Activity. Aliquots (5 Al)
from the translation system or renaturation buffer were used
for measurement of bioluminescence activity by the reduced
flavin mononucleotide (FMNH2) injection assay as described
(18). Luciferase activity was measured with a Turner (Palo
Alto, CA) TD-20e luminometer with one light unit corre-
sponding to 3.22 x 105 quanta per sec based on a radioactive
light standard as described (18).
Modeling of the Rate of 13-Subunit Folding in a Cell-Free
System. A mathematical simulation of the (3-subunit folding
and luciferase assembly reaction was performed based on the
assumption that cotranslational folding does not occur. The
kinetic profile for formation of active enzyme following dilu-
tion of unfolded (3 subunit into the cell-free system was
approximated by a polynomial fit to the data presented in Fig.
3. It was assumed that the (3 subunit released from the
ribosome would fold with the same kinetic profile. The rate of
introduction of unfolded (3 subunit from ribosomes into solu-
tion was determined by the rate of production of the full-length
protein as shown in Fig. 1 Lower. The increment of (3 subunit
produced at each time point was then allowed in the simulation
to fold and form active luciferase; the summation of the
incremental additions was the predicted formation of lucif-
erase based on the assumption of no cotranslational folding. In
a second modeling experiment, further increase in the amount
of full-length (3 subunit was blocked at 21 min to simulate the
effect of a block of synthesis. Both radioactivity incorporation
into the full-length (3 subunit and bioluminescence activity
were normalized to the final values as 100%.
RESULTS AND DISCUSSION
The biologically active form of Vibrio harveyi luciferase is an
a(3 heterodimer. Unfolded ( subunit can fold and assemble
with the native a subunit to form the active enzyme, while
folded ( subunit will not interact with folded a subunit (10,
11). Therefore, we have added native a subunit to the cell-free
protein synthesis system used to produce (3 subunit and
monitored the rate at which the native a(3 enzyme was formed
in the reaction. The concentration of a subunit used in the
study was sufficiently high that the second-order a-(3 subunit
association reaction was faster than the folding of the (
subunit, so that folding of the nascent chain was rate-limiting.
Expression in vitro employed an E. coli cell-free system
supplemented with mRNA encoding luciferase (3 subunit.
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Purified native a subunit was added at a final concentration of
10 ,tg/ml prior to initiation of translation. Translation reac-
tions were maintained at 29°C, since higher temperatures
promoted formation of inactive subunits (data not shown).
The same temperature dependence of luciferase folding and
assembly in vivo and refolding in vitro has been observed (19).
The time dependence of 13-subunit synthesis and appearance of
enzymatically active a(3 dimer are shown in Fig. 1. Full-length
3subunit is the predominant product in the translation system
in vitro (Fig. 1 Upper). To quantitate (3-subunit synthesis,
incorporation of [35S]methionine in the polypeptide was de-
termined by use of a (3-particle imager. The results, together
with the kinetics of appearance of luciferase activity, are shown
in Fig. 1 Lower. The kinetics of the two processes exhibit
similar patterns, although there is a 3- to 4-min lag between
completion of synthesis of the entire (3subunit and appearance
of active a(3 heterodimer. This lag may reflect not only
folding/association events following release of the (3 subunit
but also termination and release of the completed polypeptide
from the ribosome (20, 21).
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FIG. 1. Time course of luciferase ,B-subunit synthesis in an E. coli
cell-free system and appearance of luciferase a(3 heterodimer enzy-
matic activity. (Upper) Kinetics of full-length (3-subunit synthesis as
revealed by gel electrophoresis followed by autoradiography. (Lower)
Quantitative analysis of (-subunit synthesis and appearance of the
enzymatic activity. Translation was carried out in a total volume of 180
,ul with the luciferase (3-subunitmRNA in presence of [35S]methionine
and supplemented with native luciferase a subunit. At each indicated
time point, two 5-,ul aliquots of the translation mixture were removed
simultaneously. One was used for measurement of bioluminescence
activity (-), and the other aliquot was subjected to electrophoretic
analysis to monitor polypeptide synthesis. The same gel was used for
quantitation of radioactivity incorporation on a (3-imager. The total
number of counts in each sample corresponds to the radioactivity
detected for polypeptides with the molecular weight of full-length (3
subunit (V). The experimental error of the measurements was ±7%.
Specific enzymatic activity of luciferase obtained with synthesized (3
subunit was 1.6 x 1013 + 0.4 x 1013 quanta per sec per mg. L.U., light
unit(s).
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FIG. 2. Effect of blocking translation on the time course of appearance of luciferase activity in an E. coli translation system. (Left) The
[35S]methionine translation mixture for 13-subunit synthesis supplemented with a subunit was prepared in a total volume of 180 ,ul with luciferase
13-subunit mRNA and was subdivided into two portions which were incubated simultaneously. In one portion, MgCl2 was added after 21 min of
incubation to block further elongation (time indicated by arrow). At each time point, two 5-,ul aliquots were removed simultaneously, one for
electrophoretic analysis (data not shown) and the other for determination of the enzymatic activity. Active enzyme from the control (without block)
was determined at 30 min, and light intensity was found to be 91 light units (L.U.). This level was greater than that observed in the experiment
shown in Fig. 1, probably because a different batch of mRNA was employed. (Right) Cell-free translation with unlabeled methionine (final
concentration, 50 ,uM). The translation mixture (total volume, 180 ,lI) was divided into two portions and kept at 4°C. Translation was carried out
with the addition of MgCl2 at 21 min to block elongation in one portion (time indicated by arrow) (0) and without the translational block in the
other portion (0). The enzymatic activity of 5-,ul aliquots was measured.
To obtain some understanding of the rate of folding and
assembly of the 1B subunit following release from the ribosome,
we have used a different experimental approach. By increasing
the Mg2+ concentration, translation was blocked; this treat-
ment has been shown to "freeze" nascent polypeptides on
ribosomes and completely block further synthesis (6, 22). Any
further increase in enzymatic activity following the block in
translation should reflect only folding/association events of
the 13 subunit that had already been released into the reaction
mixture. A translation block was applied at 21 min, which was
in the linear range of increase in enzymatic activity in the
cell-free system. Quantitative analysis of the translation prod-
ucts confirmed that no further synthesis occurred after the
Mg2+ concentration was increased. Within 1 min of application
of the translation block, the luciferase activity reached a
plateau at 27 light units (Fig. 2 Left), while the control reaction
without the block reached 91 light units at 30 min (not shown).
In other translation mixtures, unlabeled methionine (instead
of [35S]methionine) at a concentration identical to that of other
amino acids was added. The results were the same: after
application of the block of translation, the activity reached a
plateau of 28 light units within 2 min, while without the block,
the activity reached 74 light units at 30 min (Fig. 2 Right). The
duration of the lag between cessation of synthesis of the
subunit and cessation of formation of active luciferase was 2
min or less, while the delay in appearance of luciferase
following completion of the full-length subunit, shown in Fig.
1, was 3-4 min. In the experiment presented in Fig. 1, the delay
may be due both to termination and release of the full-length
protein and subsequent folding, while in the experiment
presented in Fig. 2, we believe that the delay is due only to
folding.
To directly compare the rate of 13-subunit renaturation
under the same conditions as were used for translation of the
mRNA, urea-denatured subunit was added to the translation
mixture supplemented with a subunit but without mRNA. The
13 subunit was used at approximately the same concentration
as was obtained in the translation system in vitro (as quanti-
tated by [35S]methionine incorporation in the translation
experiments). The appearance of luciferase activity was mon-
itored as a function of time (Fig. 3). Following a lag of about
3 min, enzyme activity increased rapidly, reaching about 50%
of the final value in about 9 min. The same experiment was
repeated by using a buffer resembling that of the translation
mixture supplemented with a subunit but without the cellular
constituents contained in the cell-free translation system (Fig.
3). In this case, after a comparable lag, enzyme activity
increased more slowly, reaching 50% of the final value in about
13 min. Different concentrations of Mg2+ have been found to
have no effect on the rate of formation or yield of luciferase
(data not shown). A possible explanation of the effect of
components of the cell-free system on the rate of refolding is
the action of chaperones (7, 8). At subunit concentrations of
10-50 ,ug/ml, excellent yields of active enzyme are obtained
without the aid of chaperones (9, 10). While 13-subunit rena-
turation in the cell-free system is faster than in the buffer, it is
still much slower than folding of subunit during synthesis.
The most obvious interpretation of the results of the exper-
iments described above is that the subunit, when it is released
from the ribosome, has attained appreciable structure so that
the time required to complete the folding process is signifi-
cantly less than is required for the denatured polypeptide to
refold under identical condition. We have modeled the fold-
ing/assembly reaction based on the following assumptions: (i)
synthesis of the 13 subunit occurs at the rate shown by the data
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FIG. 3. Renaturation of full-length luciferase subunit. Renatur-
ation in the translation mixture was initiated by addition of urea-
denatured 13 subunit to 180 ,ul of the translation mixture with added
a subunit but without added mRNA; 5-,l aliquots were removed for
measurement of enzymatic activity (0). Renaturation in buffer was
initiated by addition of urea-denatured 13 subunit to 1 ml of buffer
supplemented with a subunit; 5-,ul aliquots were removed to measure
enzymatic activity (0). Both renaturation mixtures contained the same
final concentration of urea-denatured subunit (0.15 jig/ml). L.U.,
light unit(s).
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FIG. 4. Mathematical modeling of the (-subunit folding and
luciferase assembly reaction. V, Time course for production of full-
length subunit (data from Fig. 1 Lower); -, simulated time course
for formation of active luciferase from the synthesized (3 subunit
[calculated by assuming that the (3 subunit (released in an unfolded
state) folded and assembled into active enzyme at the same rate as
denatured 3subunit refolded under identical conditions (Fig. 3)]; ---,
simulated time course for formation of active luciferase following a
block in synthesis at 21 min. Further details are given in the text.
presented in Fig. 1 Lower; (ii) the 13 subunit begins to fold only
after release from the ribosome into the medium; (iii) the rate
of folding of 13 subunit after release into the medium is the
same as that of subunit diluted from denaturant into the
cell-free system (Fig. 3). The simulation was conducted by
assuming that unfolded 13 subunit was introduced into the
refolding reaction at the rate with which full-length 13 subunit
was synthesized and that the unfolded polypeptides folded at
the same rate as did unfolded subunit introduced from
denaturant.
As may be seen from the results of the modeling (Fig. 4), if
the 13 subunit were released from the ribosome into the
solution as an unfolded polypeptide, the native structure would
form much more slowly than was observed experimentally.
The delay between synthesis of the full-length polypeptide and
appearance of the activity would have been about 10 min. To
simulate the kinetics of appearance of luciferase activity
following the Mg2+-induced block of synthesis, the amount of
13 subunit synthesized prior to the 21-min time point, the time
at which the block was applied, was held constant. The
subunit that had been synthesized prior to the block but folded
after the block of synthesis would result in a large increase in
the final amount of active enzyme (in contrast to Fig. 3); the
plateau should not occur until about 17 min (see Fig. 4). Thus,
the results expected based on the assumption of posttransla-
tional folding of full-length 13 subunit are in clear contradiction
to the experimentally observed rate of formation of active
luciferase in the course of 13-subunit synthesis.
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FIG. 5. Testing for the possibility of formation of enzymatically
active a13 luciferase heterodimer by interaction of the nascent ,B
subunit with free a subunit. Translation was carried out in a cell-free
system supplemented with mRNA for subunit without a stop codon
in the presence of a subunit. The translation mixture was applied to
a molecular sieve column (Ultrogel AcA34) to separate the ribosomal
fraction from soluble proteins. Total radioactivity in 10-,ul aliquots (V)
and enzymatic activity in 100-,l aliquots (-) were determined for each
fraction.
It has been shown in a number of studies that the ribosome
shelters 20-30 C-terminal amino acid residues during protein
synthesis. Even though previous studies have implicated the
C-terminal region of the 8 subunit in the heterodimerization
process (19), we decided to test whether the 13 subunit may
form a structure during synthesis with which the a subunit can
combine to form an active complex prior to completion of
synthesis and release from the ribosome. Luciferase ,B-subunit
mRNA devoid of a stop codon was translated to produce a
stable ternary complex of polypeptide-mRNA-ribosome. As
in the above experiments, the cell-free system was supple-
mented with a subunit. The same level of polypeptide synthesis
was obtained as for the mRNA with an in-frame stop codon.
However, luciferase activity in the translation system was at the
background level. Upon size-exclusion chromatography of the
translation system, the radioactivity appeared in two peaks-
the void volume, where extremely large complexes and parti-
cles including ribosomes are expected to be eluted, and the
total accessible volume, where free [35S]methionine is eluted
(Fig. 5). Electrophoretic analysis of chromatographic fractions
revealed that the 13 subunit was eluted predominantly in the
void volume (not shown). There was no luciferase activity in
these fractions, and no activity appeared after incubation of
ribosomal complexes with additional a subunit. Enzymatic
activity in the zone of free proteins is probably due to the a
subunit alone (11) and perhaps to a small amount of luciferase
(a13) resulting from release of subunit. By treatment with
puromycin, which causes the release of nascent polypeptides
from ribosomes, it has been shown that the 13 subunit produced
from mRNA lacking a stop codon indeed was predominantly
Table 1. Probing the ribosome-bound state of the nascent d subunit by puromycin
Ribosomal fraction
Translation Without
mixture With puromycin puromycin
Total Pellet Total Pellet Total Pellet
Radioactivity, counts x 10-6 7.5 5.4 0.54 0.115 0.54 0.50
,B subunit, % of total 100 72 100 21 100 92
Translation was carried out in a cell-free system (in 100 ,ul) with the mRNA lacking a stop codon in
the presence of a subunit. The translation mixture was subjected to centrifugation through 10% sucrose.
The pellet was dissolved in 100 ,ul of the buffer; two 10-,l aliquots were removed, their volume was
adjusted to 50 ,ul with the same buffer, a subunit was added, and the mixtures were incubated with or
without puromycin. After recentrifugation under the same conditions, the pellets were dissolved in SDS
buffer. After electrophoretic separation, incorporation of radioactivity into full-length a subunit was
quantitated.
Proc. Natl Acad Sci USA 92 (1995)
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ribosome-bound (see Table 1). Large complexes and particles
from a translation mixture were pelleted by centrifugation.
This fraction contained the majority of the full-length (3
subunit. Addition of puromycin caused a dramatic decrease of
high molecular weight (3subunit, thus directly confirming that
the polypeptide existed as a peptidyl-tRNA in the ribosome.
The polypeptide released by puromycin formed enzymatically
active luciferase in the presence of a subunit; 42 light units
were obtained from an amount of the puromycin-treated
ribosomal fraction that was derived from 5 ,ul of the original
translation mixture. From these experiments, the possibility of
an inactive complex between a subunit and the nascent (3
subunit cannot be excluded. These results demonstrate that the
final folding step of the (3 subunit, that is, formation of the
enzymatically active a(3 heterodimer, can occur only after
release of the j subunit from the ribosome.
Based on the results presented in this study, we conclude
that the luciferase (3 subunit folds cotranslationally. Clearly,
the polypeptide cannot fold prior to synthesis. The C-terminal
region of the (3 subunit is produced about 10-11 min after
initiation of translation. The time required for folding of at
least this portion of the , subunit, known to be involved in
heterodimerization, is less than the time required to refold the
covalently intact but unfolded 13 subunit upon dilution from
urea. Biosynthetic folding of luciferase, including af het-
erodimer association, is completed in less than 2 min after the
, subunit is released from the ribosome. The apparent expla-
nation for this observation is that cotranslational folding
contributes to the rate of formation of native protein structure
in the cell-free system and therefore, we believe, within the
living cell. While components of cell extracts (chaperones,
peptidylprolyl isomerases, etc.) play important roles in protein
folding, they cannot be per se a decisive factor determining the
fast rate of biosynthetic folding, at least for this protein.
Whatever the interactions in the biosynthetic folding of the (3
subunit, folding of the polypeptide during its synthesis on the
ribosome is a prerequisite condition for the fast acquisition of
native structure.
These data suggest that the fully unfolded form of a com-
plete polypeptide does not exist within the living cell. This is
in clear contrast with the starting point of refolding experi-
ments in vitro. Questions regarding possible differences in the
pathway(s) of polypeptide refolding and biosynthetic folding
remain open. In the case of luciferase, it appears that the
overall folding mechanism is similar whether the 13 subunit is
produced from ribosomes or supplied unfolded from urea.
That is, the (3 subunit folds into a heterodimerization-
competent monomeric structure that combines with the a
subunit to form, ultimately, the active luciferase heterodimer.
Vectorial appearance of the nascent polypeptide from the
N-terminal to the C-terminal end may affect, at least, the
temporal organization of folding events within the (3-subunit
monomer.
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